Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · IEX Real-Time Price · USD

1.000

-0.230 (-18.70%)

At close: May 3, 2024, 4:00 PM

1.030

+0.030 (3.00%)

After-hours: May 3, 2024, 7:59 PM EDT

Allarity Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-20.42	-21.05	-26.65	-6.6	-0.01
Depreciation & Amortization	0.04	0.06	0.11	0.09	0.09
Share-Based Compensation	-0.07	1.75	6.37	0.62	0.33
Other Operating Activities	-0.81	-2.57	5.29	-1.35	-10.52
Operating Cash Flow	-12.75	-16.82	-14.89	-7.25	-10.11
Capital Expenditures	0	0.79	1.01	-0	-0.01
Change in Investments	0	0	0	0	0.24
Investing Cash Flow	0	0.79	1.01	-0	0.23
Share Issuance / Repurchase	16.9	0	34.89	3.7	13.56
Debt Issued / Paid	-2.65	1	0.97	2.55	3.55
Other Financing Activities	-3.25	-2.31	-2.04	-0.22	-5.9
Financing Cash Flow	11	-1.31	33.82	6.03	11.2
Exchange Rate Effect	-0.11	-0.19	-0.68	-0.01	-0.03
Net Cash Flow	-1.75	-17.34	19.94	-1.22	1.32
Free Cash Flow	-12.75	-16.03	-13.88	-7.25	-10.12
Free Cash Flow Margin	-	-	-	-	-8434166.67%
Free Cash Flow Per Share	-128.04	-47100.66	-61120.97	-62213.23	-223466.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).